Mitochondrial calcium uptake capacity as a therapeutic target in the R6/2 mouse model of Huntington's disease.
about
Tissue transglutaminase overexpression does not modify the disease phenotype of the R6/2 mouse model of Huntington's diseaseMouse models of polyglutamine diseases in therapeutic approaches: review and data table. Part II.Neurodevelopmental impairment following neonatal hyperoxia in the mouse.Metabolic state determines sensitivity to cellular stress in Huntington disease: normalization by activation of PPARγ.Implantation of undifferentiated and pre-differentiated human neural stem cells in the R6/2 transgenic mouse model of Huntington's diseaseAltered Ca(2+) signaling in skeletal muscle fibers of the R6/2 mouse, a model of Huntington's diseaseCa(2+) handling in isolated brain mitochondria and cultured neurons derived from the YAC128 mouse model of Huntington's diseaseDisruption of Purkinje cell function prior to huntingtin accumulation and cell loss in an animal model of Huntington disease.Mitochondrial Ca(2+) and neurodegenerationPurkinje cell dysfunction and loss in a knock-in mouse model of Huntington diseaseAllelic series of Huntington's disease knock-in mice reveals expression discorrelates.Hyperactivity and cortical disinhibition in mice with restricted expression of mutant huntingtin to parvalbumin-positive cells.Mitochondrial permeability transition pore induces mitochondria injury in Huntington disease.Oxidative metabolism and Ca2+ handling in isolated brain mitochondria and striatal neurons from R6/2 mice, a model of Huntington's disease.Mitochondrial dysfunction and nicotinamide dinucleotide catabolism as mechanisms of cell death and promising targets for neuroprotection.Huntington's disease, calcium, and mitochondria.Mutant Huntingtin and Elusive Defects in Oxidative Metabolism and Mitochondrial Calcium Handling.Towards an Understanding of Energy Impairment in Huntington's Disease Brain.Adeno-Associated Viral Vector Serotype DJ-Mediated Overexpression of N171-82Q-Mutant Huntingtin in the Striatum of Juvenile Mice Is a New Model for Huntington's Disease.
P2860
Q24618141-87BC6E6F-2751-4E57-8810-6BABB9635279Q27005950-2EEF1FA9-CF5E-49DD-9C9E-1E3FEFAF9D2CQ30573333-2EEF9CCB-D9CA-45DE-B9B1-223850FE774EQ34140579-E0569881-7A25-4D95-BCC3-54B6E0B9A0D4Q34372919-A3DE5C64-2E9B-443C-B6E9-562A72BDB216Q34409630-F781ED56-E126-42A3-9783-7A549E701689Q35893954-57F60AA2-4914-4DF1-98A3-A7BC7AE4B8F5Q36007592-78533417-8BA9-49C2-81D0-4004C3C046D0Q36095330-81EABE22-20D2-4A50-8664-0B5B28B3321DQ36553261-109F1145-64B3-425C-9840-0E97671D0131Q36722685-2F2A12E8-4AEE-49AA-84D5-8F358E5BEC9EQ37424600-5297F14A-63E3-4944-B9C2-D4895C3C2F22Q37427280-A4AAAFAD-6F67-412C-98EF-2753762DA296Q37530288-49C1D323-AD23-4635-94FC-9A640AA9DB21Q37864604-64A2E4D8-2B01-473D-B37F-0ABEF4D16E58Q37889820-6F49CF1C-287F-453D-B4C2-AAA2E01A9C10Q38458943-47C33787-61B8-42E3-B469-8379D2C41122Q47442924-C8B1F37E-DB62-43E0-9989-0D1871DC4F9DQ55405670-597A4549-7E9D-42CD-9738-76B99DD11071
P2860
Mitochondrial calcium uptake capacity as a therapeutic target in the R6/2 mouse model of Huntington's disease.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Mitochondrial calcium uptake c ...... model of Huntington's disease.
@ast
Mitochondrial calcium uptake c ...... model of Huntington's disease.
@en
Mitochondrial calcium uptake c ...... model of Huntington's disease.
@nl
type
label
Mitochondrial calcium uptake c ...... model of Huntington's disease.
@ast
Mitochondrial calcium uptake c ...... model of Huntington's disease.
@en
Mitochondrial calcium uptake c ...... model of Huntington's disease.
@nl
prefLabel
Mitochondrial calcium uptake c ...... model of Huntington's disease.
@ast
Mitochondrial calcium uptake c ...... model of Huntington's disease.
@en
Mitochondrial calcium uptake c ...... model of Huntington's disease.
@nl
P2093
P2860
P356
P1476
Mitochondrial calcium uptake c ...... model of Huntington's disease.
@en
P2093
Andrew Kneynsberg
Ashish Kumar
Giselle M Perry
Mary Y Heng
Mathieu Lesort
Peter J Detloff
Roger L Albin
Sara Tallaksen-Greene
Thomas van Groen
P2860
P304
P356
10.1093/HMG/DDQ247
P577
2010-06-17T00:00:00Z